{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:08:23Z","timestamp":1778713703725,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007710","name":"University of Connecticut","doi-asserted-by":"publisher","award":["CT-005404"],"award-info":[{"award-number":["CT-005404"]}],"id":[{"id":"10.13039\/100007710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.neuropharm.2020.108325","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:46:23Z","timestamp":1600469183000},"page":"108325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology"],"prefix":"10.1016","volume":"183","author":[{"given":"Renee A.","family":"Rotolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose E.","family":"Presby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sokaina","family":"Asar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Hau","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraser","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108325_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuropharm.2014.05.039","article-title":"Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function","volume":"85","author":"Azzinnari","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nlm.2016.07.015","article-title":"Neural substrates underlying effort, time, and risk-based decision making in motivated behavior","volume":"133","author":"Bailey","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108325_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/bne0000361","article-title":"Dissociating the effects of dopamine D2 receptors on effort-based versus value-based decision making using a novel behavioral approach","volume":"134","author":"Bailey","year":"2020","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108325_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/sbx063","article-title":"Paradigms for assessing hedonic processing and motivation in humans: relevance to understanding negative symptoms in psychopathology","volume":"43","author":"Barch","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2020.108325_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ynstr.2018.01.004","article-title":"Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour in mice","volume":"8","author":"Bergamini","year":"2018","journal-title":"Neurobiology of stress"},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108325_bib7","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/npp.2016.15","article-title":"Perturbations in effort-related decision-making driven by acute stress and corticotropin-releasing factor","volume":"41","author":"Bryce","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fnbeh.2019.00289","article-title":"Preference for exercise vs. More sedentary reinforcers: validation of an animal model of tetrabenazine-induced anergia","volume":"13","author":"Carratal\u00e1-Ros","year":"2020","journal-title":"Front. Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108325_bib107","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.clinthera.2012.06.010","article-title":"Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature","volume":"34","author":"Chen","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuropharm.2020.108325_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cortex.2015.04.003","article-title":"Dopamine enhances willingness to exert effort for reward in Parkinson's disease","volume":"69","author":"Chong","year":"2015","journal-title":"Cortex"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108325_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00127-018-1492-3","article-title":"Lifetime prevalence and age-of-onset of mental disorders in adults from the Argentinean study of mental health epidemiology","volume":"53","author":"Cia","year":"2018","journal-title":"Soc. Psychiatr. Psychiatr. Epidemiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108325_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/0269881113514878","article-title":"Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union","volume":"28","author":"Cooper","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2016.08.004","article-title":"Co-occurrence and symptomatology of fatigue and depression","volume":"71","author":"Corfield","year":"2016","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108325_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand?","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.108325_bib15","first-page":"247","article-title":"Cytokine, sickness behavior, and depression","volume":"29","author":"Dantzer","year":"2009","journal-title":"Immunol. Allergy Clin."},{"key":"10.1016\/j.neuropharm.2020.108325_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/7854_2016_6","article-title":"Role of the kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches","volume":"31","author":"Dantzer","year":"2019","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108325_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.psyneuen.2007.10.008","article-title":"Identification and treatment of symptoms associated with inflammation in medically ill patients","volume":"33","author":"Dantzer","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrclinonc.2012.88","article-title":"Translational approaches to treatment-induced symptoms in cancer patients","volume":"9","author":"Dantzer","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnbeh.2020.00073","article-title":"Inhibition of catechol-O-methyltransferase does not alter effort-related choice behavior in a fixed ratio\/concurrent chow task in male mice","volume":"14","author":"DeBrosse","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.105.091231","article-title":"Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl) piperazine] and benztropine analogs","volume":"315","author":"Desai","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108325_bib21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/jpet.110.165746","article-title":"Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux","volume":"333","author":"Desai","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108325_bib23","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00213-020-05521-z","article-title":"Chronic corticosterone shifts effort-related choice behavior in male mice","volume":"237","author":"Dieterich","year":"2020","journal-title":"Psychopharm"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108325_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0033-3182(94)71797-7","article-title":"Bupropion for the treatment of fatigue associated with multiple sclerosis","volume":"35","author":"Duffy","year":"1994","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuropharm.2020.108325_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/da.22199","article-title":"Clinical relevance of fatigue as a residual symptom in major depressive disorder","volume":"31","author":"Fava","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2020.108325_bib28","doi-asserted-by":"crossref","first-page":"II73","DOI":"10.1007\/s00415-007-2017-2","article-title":"Neuropsychiatric syndromes associated with multiple sclerosis","volume":"254","author":"Feinstein","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108325_bib98","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/npp.2016.143","article-title":"Inflammation effects on motivation and motor activity: role of dopamine","volume":"42","author":"Felger","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108325_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cercor\/bhj143","article-title":"Amygdala-prefrontal cortical circuitry regulates effortbased decision making","volume":"17","author":"Floresco","year":"2007","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2020.108325_bib31","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/sj.npp.1301565","article-title":"Dopaminergic and glutamatergic regulation of effort- and delay-based decision making","volume":"33","author":"Floresco","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib99","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. huntington Study Group\/TETRA-HD Investigators","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neuropharm.2020.108325_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: both effects are reversed by inhibition of indoleamine 2 3-dioxygenase","volume":"54","author":"Fuertig","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.108325_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbd.2014.11.022","article-title":"Dopaminergic dysfunction is associated with IL-1\u03b2-dependent mood alterations in experimental autoimmune encephalomyelitis","volume":"74","author":"Gentile","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108325_bib100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.amjopharm.2010.08.006","article-title":"Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinectic movement disorders","volume":"8","author":"Guay","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108325_bib34","first-page":"210","article-title":"A phase II study of methylphenidate for the treatment of fatigue","volume":"14","author":"Hanna","year":"2006","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.neuropharm.2020.108325_bib35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bbi.2009.06.151","article-title":"Fatigue in primary Sjogren's syndrome- A link to sickness behaviour in animals?","volume":"23","author":"Harboe","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108325_bib36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/ejn.13608","article-title":"Anterior cingulate cortex supports effort allocation towards a qualitatively preferred option","volume":"46","author":"Hart","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HRP.0000000000000230","article-title":"Gender differences in depression: biological, affective, cognitive, and sociocultural factors","volume":"28","author":"Hyde","year":"2020","journal-title":"Harv. Rev. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108325_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41398-020-00969-1","article-title":"Empirical validation of a touchscreen probabilistic reward task in rats","volume":"10","author":"Kangas","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108325_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.33588\/rn.4512.2007496","article-title":"Immune factors or depression? Fatigue correlates in Parkinson's disease","volume":"45","author":"Katsarou","year":"2007","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib40","series-title":"Design and Analysis a Researcher's Handbook","author":"Keppel","year":"1991"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108325_bib41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108325_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00134","article-title":"Chronic social stress leads to reduced gustatory reward salience and effort valuation in mice","author":"K\u00fakel\u2019ov\u00e1","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib44","first-page":"64","article-title":"Treating fatigue","volume":"14","author":"Lapierre","year":"2007","journal-title":"Int. MS J."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108325_bib101","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/jnnp-2018-318265","article-title":"Brain mechanisms underlying apathy","volume":"90","author":"Le Heron","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108325_bib102","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","article-title":"Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens","volume":"12","author":"Mai","year":"2012","journal-title":"Cogn. Affect Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108325_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-002-1273-1","article-title":"Dissociating anorexia and anhedonia elicited by interleukin-1beta: anti-depressant and gender effects on responding for \u201cfree chow\u201d and \u201cearned\u201d sucrose intake","volume":"165","author":"Merali","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","article-title":"Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface","volume":"23","author":"Miller","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.108325_bib49","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","article-title":"Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression","volume":"33","author":"Nunes","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3285-4","article-title":"Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5\/chow feeding choice task","volume":"231","author":"Nunes","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib52","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/14737175.7.10.1251","article-title":"Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion","volume":"7","author":"Pae","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2020.108325_bib53","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","article-title":"Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors","volume":"15","author":"Papakostas","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108325_bib54","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00213-015-3872-7","article-title":"Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists","volume":"232","author":"Pardo","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108325_bib55","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.neuropharm.2011.12.033","article-title":"Adenosine A 2A receptor antagonism and genetic deletion attenuate the effects of dopamine D 2 antagonism on effort-based decision making in mice","volume":"62","author":"Pardo","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib103","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2009"},{"key":"10.1016\/j.neuropharm.2020.108325_bib104","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","article-title":"Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants","volume":"102","author":"Pettibone","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbi.2010.02.006","article-title":"Linking the cytokine and neurocircuitry hypothesis of depression: a translational framework for discovery and development of novel anti-depressants","volume":"24","author":"Piser","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.108325_bib61","unstructured":"Presby, R.E.*, Rotolo, R.A.*, Hurley, Ferrigno, S., Murphy, C., McMullen, H., Desai, P., Zorda, E., Kuperwasser, F., Carratala-Ros, C., Correa, M., Salamone, J.D. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats and suppression of high effort activity by the serotonin transport inhibitor fluoxetine. Submitted, Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108325_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099320","article-title":"The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: reversal with antidepressant drugs","volume":"9","author":"Randall","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108325_bib63","doi-asserted-by":"crossref","first-page":"pyu017","DOI":"10.1093\/ijnp\/pyu017","article-title":"Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms","volume":"18","author":"Randall","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbi.2010.10.004","article-title":"Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis","volume":"25","author":"Rossi","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.108325_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2013.08.008","article-title":"The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder","volume":"55","author":"Rothschild","year":"2014","journal-title":"Compr. Psychiatr."},{"issue":"682","key":"10.1016\/j.neuropharm.2020.108325_bib67","article-title":"The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding","volume":"10","author":"Rotolo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108325_bib68","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-020-05625-6","article-title":"Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding [published online ahead of print, 2020 Aug 7]","author":"Rotolo","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"Pt 5","key":"10.1016\/j.neuropharm.2020.108325_bib69","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/brain\/aww050","article-title":"Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology","volume":"139","author":"Salamone","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2020.108325_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beproc.2016.02.008","article-title":"The pharmacology of effort-related choice behavior: dopamine, depression, and individual differences","volume":"127","author":"Salamone","year":"2016","journal-title":"Behav. Process."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108325_bib105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02245659","article-title":"Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure","volume":"104","author":"Salamone","year":"1991","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2020.108325_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025790","article-title":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors","volume":"6","author":"Schmitt","year":"2011","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108325_bib73","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/npp.2012.69","article-title":"Acute stress induces selective alterations in cost\/benefit decision-making","volume":"37","author":"Shafiei","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108325_bib106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","article-title":"Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior","volume":"196","author":"Sink","year":"2008","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108325_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31887\/DCNS.1999.1.3\/gstotz","article-title":"Psychostimulants in the therapy of treatment resistant depression review of the literature and findings from a retrospective study in 65 depressed patients","volume":"1","author":"Stotz","year":"1999","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib76","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/jpet.104.080465","article-title":"Effects of 4\u2019-chloro-3\u03b1-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine","volume":"313","author":"Tanda","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108325_bib77","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00213-013-3109-6","article-title":"Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change","volume":"229","author":"Tanda","year":"2013","journal-title":"Pharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108325_bib78","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/jpet.109.154302","article-title":"Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity","volume":"330","author":"Tanda","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108325_bib79","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1460-9568.1997.tb01375.x","article-title":"Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine","volume":"9","author":"Tanda","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108325_bib81","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fpsyt.2018.00450","article-title":"DSM-5 Criteria and depression severity: implications for clinical practice","volume":"9","author":"Tolentino","year":"2018","journal-title":"Front. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108325_bib82","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/a0028813","article-title":"Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia","volume":"121","author":"Treadway","year":"2012","journal-title":"J. Abnorm. Psychol."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108325_bib83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tics.2019.03.003","article-title":"Can't or won't? Immunometabolic constraints on dopaminergic drive","volume":"23","author":"Treadway","year":"2019","journal-title":"Trends Cognit. Sci."},{"issue":"46","key":"10.1016\/j.neuropharm.2020.108325_bib84","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1523\/JNEUROSCI.4387-11.2011","article-title":"Amping up effort: effects of d-amphetamine on human effort-based decision-making","volume":"31","author":"Wardle","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108325_bib87","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.psychres.2014.08.056","article-title":"Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients","volume":"220","author":"Yang","year":"2014","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108325_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00213-019-05343-8","article-title":"Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction","volume":"237","author":"Yang","year":"2020","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108325_bib89","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","article-title":"The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion","volume":"232","author":"Yohn","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib90","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pbb.2015.05.003","article-title":"The role of dopamine D1 receptor transmission in effort-related choice behavior: effects of D1 agonists","volume":"135","author":"Yohn","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108325_bib91","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/npp.2015.188","article-title":"Not all antidepressants are created equal: differential effects of monoamine uptake inhibitors on effort-related choice behavior","volume":"41","author":"Yohn","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108325_bib92","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00213-015-4176-7","article-title":"Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat","volume":"233","author":"Yohn","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib93","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2016.06.004","article-title":"Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040","volume":"148","author":"Yohn","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108325_bib94","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuropharm.2016.06.018","article-title":"Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: implications for treatment of effort-related motivational symptoms in psychopathology","volume":"109","author":"Yohn","year":"2016","journal-title":"Neuropharmacology"},{"issue":"19\u201320","key":"10.1016\/j.neuropharm.2020.108325_bib95","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1007\/s00213-016-4392-9","article-title":"Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization","volume":"233","author":"Yohn","year":"2016","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2020.108325_bib96","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/npp.2017.41","article-title":"The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic","volume":"42","author":"Zhang","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108325_bib97","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.comppsych.2014.09.007","article-title":"How many different ways do patients meet the diagnostic criteria for major depressive disorder?","volume":"56","author":"Zimmerman","year":"2015","journal-title":"Compr. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:11:32Z","timestamp":1778710292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":89,"alternative-id":["S0028390820303932"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108325","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108325"}}